Thrivent Financial For Lutherans Roivant Sciences Ltd. Transaction History
Thrivent Financial For Lutherans
- $45.7 Billion
- Q2 2025
A detailed history of Thrivent Financial For Lutherans transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 99,124 shares of ROIV stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,124
Previous 98,707
0.42%
Holding current value
$1.63 Million
Previous $996,000
12.15%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
363Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$983 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$733 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$645 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$580 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$561 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $11.6B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...